These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 26117463

  • 1. 1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of Restenosis.
    Iida O, Takahara M, Soga Y, Nakano M, Yamauchi Y, Zen K, Kawasaki D, Nanto S, Yokoi H, Uematsu M, ZEPHYR Investigators.
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1105-1112. PubMed ID: 26117463
    [Abstract] [Full Text] [Related]

  • 2. Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease.
    Zen K, Takahara M, Iida O, Soga Y, Kawasaki D, Nanto S, Yokoi H, Matoba S, ZEPHYR Investigators.
    J Vasc Surg; 2017 Mar; 65(3):720-725. PubMed ID: 28073668
    [Abstract] [Full Text] [Related]

  • 3. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K, Ullery BW, Kret MR, Lee JT.
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [Abstract] [Full Text] [Related]

  • 4. Incidence and its characteristics of repetition of reintervention after drug-eluting stent implantation for femoropopliteal lesion.
    Iida O, Takahara M, Soga Y, Hirano K, Yamauchi Y, Zen K, Yokoi H, Uematsu M, ZEPHYR investigators.
    J Vasc Surg; 2016 Dec; 64(6):1691-1695.e1. PubMed ID: 27575807
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.
    Tsujimura T, Takahara M, Iida O, Soga Y, Katsuki T, Fujihara M, Kawasaki D, Kozuki A, Mano T.
    J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998
    [Abstract] [Full Text] [Related]

  • 6. A Polymer-Free Paclitaxel-Eluting Stent Versus a Bare-Metal Stent for De Novo Femoropopliteal Lesions: The BATTLE Trial.
    Gouëffic Y, Sauguet A, Desgranges P, Feugier P, Rosset E, Ducasse E, Kaladji A, Salomon du Mont L, Pernès JM, Commeau P, Lermusiaux P, Leclere B, Guyomarc'h B, Hoffmann CT, Maurel B.
    JACC Cardiovasc Interv; 2020 Feb 24; 13(4):447-457. PubMed ID: 32081238
    [Abstract] [Full Text] [Related]

  • 7. The Characteristics of In-Stent Restenosis After Drug-Eluting Stent Implantation in Femoropopliteal Lesions and 1-Year Prognosis After Repeat Endovascular Therapy for These Lesions.
    Iida O, Takahara M, Soga Y, Hirano K, Yamauchi Y, Zen K, Kawasaki D, Nanto S, Yokoi H, Uematsu M, ZEPHYR Investigators.
    JACC Cardiovasc Interv; 2016 Apr 25; 9(8):828-834. PubMed ID: 27101908
    [Abstract] [Full Text] [Related]

  • 8. A single center experience of Zilver PTX for femoro-popliteal lesions.
    Kang WY, Campia U, Didier RJ, Kiramijyan S, Koifman E, Negi SI, Lipinski MJ, Baker NC, Escarcega RO, Torguson R, Waksman R, Bernardo NL.
    Cardiovasc Revasc Med; 2016 Sep 25; 17(6):399-403. PubMed ID: 27496591
    [Abstract] [Full Text] [Related]

  • 9. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents.
    Zeller T, Dake MD, Tepe G, Brechtel K, Noory E, Beschorner U, Kultgen PL, Rastan A.
    JACC Cardiovasc Interv; 2013 Mar 25; 6(3):274-81. PubMed ID: 23517839
    [Abstract] [Full Text] [Related]

  • 10. Vessel Calcification as a Risk Factor for In-Stent Restenosis in Complex Femoropopliteal Lesions After Zilver PTX Paclitaxel-Coated Stent Placement.
    Ichihashi S, Shibata T, Fujimura N, Nagatomi S, Yamamoto H, Kyuragi R, Adachi A, Iwakoshi S, Bolstad F, Saeki K, Obayashi K, Kichikawa K.
    J Endovasc Ther; 2019 Oct 25; 26(5):613-620. PubMed ID: 31257994
    [Abstract] [Full Text] [Related]

  • 11. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
    Mori S, Hirano K, Nakano M, Muramatsu T, Tsukahara R, Ito Y, Ishimori H.
    J Endovasc Ther; 2015 Jun 25; 22(3):341-9. PubMed ID: 25862363
    [Abstract] [Full Text] [Related]

  • 12. ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions.
    Bosiers M, Setacci C, De Donato G, Torsello G, Silveira PG, Deloose K, Scheinert D, Veroux P, Hendriks J, Maene L, Keirse K, Navarro T, Callaert J, Eckstein HH, Teβarek J, Giaquinta A, Wauters J.
    J Endovasc Ther; 2020 Apr 25; 27(2):287-295. PubMed ID: 31997715
    [Abstract] [Full Text] [Related]

  • 13. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N, Takahara M, Soga Y, Nakano M, Yamauchi Y, Zen K, Kawasaki D, Yokoi H, Tosaka A, Tanaka N, Iida O.
    J Endovasc Ther; 2016 Aug 25; 23(4):642-7. PubMed ID: 27099284
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM, Lammer J, Willfort-Ehringer A, Matzek W, Gschwandtner M, Javor D, Funovics M, Schoder M, Koppensteiner R, Loewe C, Ristl R, Wolf F.
    JACC Cardiovasc Interv; 2016 Jul 11; 9(13):1386-92. PubMed ID: 27388828
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K, Fujii K, Kawasaki D, Shibuya M, Fukunaga M, Imanaka T, Tamaru H, Sumiyoshi A, Nishimura M, Horimatsu T, Saita T, Okada K, Kimura T, Honda Y, Fitzgerald PJ, Masuyama T, Ishihara M.
    J Endovasc Ther; 2016 Jun 11; 23(3):424-32. PubMed ID: 27044270
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness of Zilver PTX eluting stent in TASC C/D lesions and restenosis.
    Leopardi M, Houbballah R, Becquemin JP.
    J Cardiovasc Surg (Torino); 2014 Apr 11; 55(2):229-34. PubMed ID: 24670831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.